Cryotherapy in CI has not been reported in PubMed in English language. The exact mechanism of cryotherapy for treatment of CI is unclear. Liquid nitrogen cryotherapy treatment of areas helps to remove hyperkeratotic, macerated tissue. It may be speculated that on rapid cooling, formation of intracellular ice crystals induces dehydration and pH changes, disrupting the infected cells along with Candida spp. 4, 5 Slow thawing leads to prolonged exposure to toxic substrates during recrystallization, which increases cell damage. Cryotherapy may also cause denaturation of fungal cell wall proteins. Freezing may also remove antigen-antibody complexes. 4, 5 Crust formation following the procedure as a result of local ischemia may help to clear chronic infective tissue. 4, 5 The limitations in our study include small sample size, no blinding or randomization, and no identification of subtypes of Candida spp., which could not be performed on account of lack of resources.
Cryotherapy is a potentially effective, safe, easily available, and cost-effective therapeutic approach to treat unresponsive CI. Larger multicenter studies are required to substantiate the efficacy and safety of this approach. protective barrier over the wound, prevent desiccation, and potentially speed healing time for wounds healing by second intention to avoid a second wound associated with the donor site of an autologous skin graft. To date, there are limited reports of the use of biosynthetic dressings in dermatologic surgery.
After institutional review board approval, we conducted a retrospective case series in which we reviewed all 128 cases in which porcine xenografts (EZ-Derm, M€ olnlycke Health Care, Gothenburg, Sweden) were applied in a single institution's dermatologic surgery unit during January 2010-December 2016. All xenografts were similarly trimmed to the size and shape of the defect and sutured with absorbable epidermal sutures. Patients were instructed to apply plain petrolatum 1-2 times per day, and the xenografts were allowed to degrade naturally.
In total, 128 surgical defects in 106 patients (mean age 71.9 years) were repaired with a xenograft. Demographic data and surgical defect locations are listed in Table I . Most patients were men (76.4%), nonsmokers (87.7%), and not on any anticoagulants (57.6%) or immunosuppressants (85.8%). The mean area of the surgical defects was 7.4 cm 2 (median 3.9 cm 2 , range 0.13-64 cm 2 ). Reported postoperative issues included pain (8.6%), hypergranulation (4.7%), and suspected infection (n ¼ 4; 3.1%). The lower leg had the highest rate of postoperative infection at 12.5%. Of the 4 suspected infections, 2 were confirmed infections (1 was Pseudomonas aeruginosa, 1 was Staphylococcus aureus) while the other 2 were treated on the basis of clinical suspicion.
The surgical defect sizes and sites varied considerably, and we have observed acceptable cosmetic outcomes for all defects (Fig 1) . Complications were limited with the leg having the highest infection rate, similar to the findings by Yang et al. 1 Despite 42.5% of patients being on an anticoagulant, we had no documented cases of postoperative bleeding. Patient-reported complaints of pain were recorded in 8.6% of cases, with 63.6% (7/11) occurring on an extremity, probably secondary to postoperative edema.
Porcine xenografts are being used increasingly, [1] [2] [3] [4] and their added cost on health care spending must be considered against their potential benefits. Unfortunately, published reports on their use remain limited. This study demonstrates that xenograft placement can be safe and well tolerated with broad utility in multiple anatomic locations and has substituted the need for split thickness skin grafts in our practice. Our retrospective chart review did not allow for an accurate assessment of healing times, and a prospective study is warranted to address if xenografts are indeed superior to secondary intention in regards to healing time, postoperative pain, 5 or wound contracture. However, our data confirms that xenografts are associated with minimal pain and low rates of infection, and avoid the morbidity of a donor site when used in place of a split thickness skin grafts. To the Editor: Patients often object to surgical smoke, and evidence suggests that it may be harmful. [1] [2] [3] [4] [5] Citing this, we conducted a prospective, singleblinded, randomized controlled trial on smoke evacuation with 160 consecutive adult patients presenting for Mohs micrographic surgery to determine how smoke evacuation affects patients. To avoid response bias, patients were asked to participate in a study of the impact of sights, sounds, and smells on their experience during dermatologic surgery. Patients were not aware of smoke evacuation randomization until a debriefing following questionnaire completion. After informed consent had been obtained, patients were randomized into 2 groups: a treatment group with smoke evacuation used during the entire procedure (Mohs micrographic surgery and reconstruction) and a control group with sham smoke evacuation. Patient blinding was ensured by using the same equipment and running the smoke evacuator identically with the treatment and control groups, except that the hose connecting the evacuation pencil to the evacuator was disconnected with the control group. Following surgery, patients were asked to respond to a questionnaire. Again, to prevent response bias, patients were asked questions about their experience with lights, smoke, and noises during their procedure. Responses were elicited on an ordinal scale of 1 to 10, with anchoring descriptions provided for points 1
